Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.
3.

Block of HIV-1 infection by a combination of antisense tat RNA and TAR decoys: a strategy for control of HIV-1.

Chang HK, Gendelman R, Lisziewicz J, Gallo RC, Ensoli B.

Gene Ther. 1994 May;1(3):208-16.

PMID:
7584083
4.

Intracellular expression of RNA transcripts complementary to the human immunodeficiency virus type 1 gag gene inhibits viral replication in human CD4+ lymphocytes.

Veres G, Escaich S, Baker J, Barske C, Kalfoglou C, Ilves H, Kaneshima H, Böhnlein E.

J Virol. 1996 Dec;70(12):8792-800.

6.

Protection of a T-cell line from human immunodeficiency virus replication by the stable expression of a short antisense RNA sequence carried by a shuttle RNA molecule.

Cagnon L, Cucchiarini M, Lefebvre JC, Doglio A.

J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Aug 1;9(4):349-58.

PMID:
7541291
7.

Inhibition of HIV replication by sense and antisense rev response elements in HIV-based retroviral vectors.

Kim JH, McLinden RJ, Mosca JD, Vahey MT, Greene WC, Redfield RR.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Aug 1;12(4):343-51.

PMID:
8673542
8.

Comparative analyses of intracellularly expressed antisense RNAs as inhibitors of human immunodeficiency virus type 1 replication.

Veres G, Junker U, Baker J, Barske C, Kalfoglou C, Ilves H, Escaich S, Kaneshima H, Böhnlein E.

J Virol. 1998 Mar;72(3):1894-901.

10.

Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA.

Lo KM, Biasolo MA, Dehni G, Palú G, Haseltine WA.

Virology. 1992 Sep;190(1):176-83.

PMID:
1529527
12.

A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection.

Biasolo MA, Radaelli A, Del Pup L, Franchin E, De Giuli-Morghen C, Palu G.

J Virol. 1996 Apr;70(4):2154-61.

13.

Inhibition of HIV-1 replication in cultured cells with antisense oligonucleotides encapsulated in immunoliposomes.

Zelphati O, Zon G, Leserman L.

Antisense Res Dev. 1993 Winter;3(4):323-38.

PMID:
8155974
16.

An autoregulated dual-function antitat gene for human immunodeficiency virus type 1 gene therapy.

Lisziewicz J, Sun D, Trapnell B, Thomson M, Chang HK, Ensoli B, Peng B.

J Virol. 1995 Jan;69(1):206-12.

18.

Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region.

Renneisen K, Leserman L, Matthes E, Schröder HC, Müller WE.

J Biol Chem. 1990 Sep 25;265(27):16337-42.

20.

Intracellular expression of antisense RNA transcripts complementary to the human immunodeficiency virus type-1 vif gene inhibits viral replication in infected T-lymphoblastoid cells.

Barnor JS, Miyano-Kurosaki N, Yamaguchi K, Sakamoto A, Ishikawa K, Inagaki Y, Yamamoto N, Osei-Kwasi M, Ofori-Adjei D, Takaku H.

Biochem Biophys Res Commun. 2004 Jul 23;320(2):544-50.

PMID:
15219863

Supplemental Content

Support Center